✦ LIBER ✦

Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection

✍ Scribed by Kerry Atkinson; Kathryn Downs; Marie Golenia; James Biggs; Gai Marshall; Anthony Dodds; Alan Concannon

Book ID: 114712540
Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 514 KB
Volume: 79
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1991.tb08007.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylaxis of cytomegalovirus infection

Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation

✍ Jonathan C. Yau; Meletios A. Dimopoulos; Susan D. Huan; Jeffrey J. Tarrand; Vern 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

Cytomegalovirus infection in bone marrow

Cytomegalovirus infection in bone marrow transplantation: the case for using prophylactic specific immunoglobulin

✍ Jacqueline J. Martindale; Ulrich Ganzinger 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 793 KB

Use of leflunomide in an allogeneic bone

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

✍ Avery, R K; Bolwell, B J; Yen-Lieberman, B; Lurain, N; Waldman, W J; Longworth, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Clinical strategies for the management o

Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant

✍ Prentice, H G; Kho, P 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

Incidence and prognosis of cytomegalovir

Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation

✍ Dr. D. Guyotat; R. Gibert; J. Chomel; E. Archimbaud; S. Bossard; J. Maupas; D. F 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

The incidence and the outcome of cytomegalovirus (CMV) infections were evaluated in 83 adult recipients of allogenic bone marrow transplantation. Virological and serological surveillance was performed weekly for 3 months posttransplant, and then every other week or every month until 1 year. CMV infe

Foscarnet for prevention of cytomegalovi

Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir

✍ Ippoliti, C; Morgan, A; Warkentin, D; van Besien, K; Mehra, R; Khouri, I; Giralt 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB